A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.

Proc Natl Acad Sci U S A

Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486.

Published: May 1992

Protein carriers vary in their ability to increase the immunogenicity of poorly immunogenic or T-lymphocyte-independent antigens. We examined one such carrier, the outer membrane protein complex derived from Neisseria meningitidis serogroup B strain B11, in an attempt to determine why this outer membrane protein complex was more immunogenic in young infants and in relevant animal models than two other carriers used in conjugates made with Haemophilus influenzae type b polysaccharide, a T-cell-independent antigen. A single protein of the outer membrane protein complex, the class 2 porin protein, was purified and shown to function as a T-helper lymphocyte carrier protein. Unexpectedly, it was also found to have mitogenic activity for lymphocytes that was not due to lipopolysaccharide. This mitogenic activity appears to date to be unique to this carrier protein of the carrier proteins tested and may contribute to the ability of the H. influenzae type b conjugate vaccine made with the outer membrane protein complex to generate IgG anti-polysaccharide antibody responses in mice and infant monkeys and protective immune responses in infants less than 6 months of age.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC49137PMC
http://dx.doi.org/10.1073/pnas.89.10.4633DOI Listing

Publication Analysis

Top Keywords

outer membrane
16
membrane protein
16
protein complex
16
mitogenic activity
12
protein
9
derived neisseria
8
neisseria meningitidis
8
activity lymphocytes
8
influenzae type
8
carrier protein
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!